Scholars Central

Conference abstractPublished 28 Apr 2016

Optimized formulation, preformulary characterization and evaluation of diethylcarbamazine citrate - Medicated chewing gum

Authors: Swati Khare

College of Pharmacy IPS Academy, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Truncate infections caused by Helminthes, or parasitic worms, affect more than two billion people worldwide. Looking at this situation, an attempt has been made to formulate a novel drug delivery system known as medicated chewing gum containing masticatory gum base with pharmacologically active ingredient Diethylcarbamazine citrate (used as a firstline agent for control and treatment of Lymphatic filariasis and for therapy of tropical pulmonary eosinophilia caused by Wuchereria bancrofti and Brugia malayi). Optimized formulations of medicated chewing gum with varying concentration of gum base were formulated. Evaluation parameter like texture analysis (hardness, firmness and springiness test) is carried out by texture analyzer apparatus (TAXT plus). Improved essentials of casting & in-vitro release profile of drug in saliva was obtained by formulation Fc3 (96.2%). Buccal absorption studies showed that 39.2% of drug absorbed within one minute when available to buccal mucosa at pH 5.5, commensurate with explain diethylcarbamazine citrate- medicated chewing gum (DECMCG) can be considered as better formulation for buccal drug delivery system in which drug is absorbed buccally and reaches the systemic circulation via jugular vein.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Swati Khare”